Search

everythinglearnresearchcommunity

for

Search:↓

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Neurosteroids show promise for treating epilepsy and more research is needed.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Hair loss requires customized treatments based on its various causes and types.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.